Chemical Characterization Under ISO 10993: What Reviewers Expect

What Chemical Characterization Actually Means

In the ISO 10993 context, chemical characterization is the structured assessment of substances that can be extracted from, leach from, or otherwise be associated with the finished medical device. That often includes material additives, processing residues, degradation products, surface-treatment remnants, and packaging-related compounds that could affect patient exposure.

Why ISO 10993-18 Matters More Now

ISO 10993-18 gives the framework for understanding the chemical makeup of the device and the significance of the observed compounds. As reviewer expectations have evolved, especially when test waivers and chemistry-driven reasoning are used, this part of the file carries more weight than it did when biological evaluation was framed primarily through default test lists.

When Reviewers Expect a Stronger Chemistry Story

Chemical characterization becomes especially important for prolonged-contact devices, implants, coated products, polymeric devices, fluid-path devices, and any submission where the safety argument depends on existing data or reduced testing. In those cases, reviewers often expect more than a statement that chemistry was "considered."

• Complex materials: additives, stabilizers, lubricants, and colorants can change the biological risk story.
• Surface treatments and coatings: these often drive the questions that testing alone does not answer.
• Legacy files: older documents often under-explain chemistry or leave it disconnected from the BER.
• Waiver-based strategies: if testing is omitted, chemistry usually needs to carry more of the burden.

How Chemistry Supports the TRA

The chemistry dataset does not close the toxicological question by itself. It becomes truly useful when it feeds into exposure assessment and toxicological interpretation. That is where TRA takes over: using the chemical findings to ask whether the observed or estimated patient exposure actually creates a meaningful toxicological concern.

Why Weak Chemistry Sections Fail

• Compound lists without meaning: the file names detected substances but never explains whether they matter.
• No bridge to exposure: reviewers cannot tell how the chemistry findings connect to real patient contact.
• Detached from the BER: chemistry is included as background data, not as part of the biological safety argument.
• Representativeness problems: the dataset does not clearly reflect the final finished device, process, or sterilized state.

When Chemistry Can Support Test Waivers

Chemical characterization is often one of the strongest foundations for endpoint waivers, especially when paired with TRA. If the chemistry profile is well understood and the toxicological conclusion is robust, the file may be able to justify why additional testing would add little meaningful information.

How to Use It Properly in a Submission

The most effective approach is to decide early in the BEP how chemistry will be used: what question it is meant to answer, how the final device will be represented, and whether the expected output is supporting data, waiver support, or a full TRA-driven safety argument. That usually produces a cleaner and more defensible file than retrofitting chemistry after reviewer questions appear.